(KVUE) Kenvue - Ratings and Ratios

Kenvue Inc. (NYSE:KVUE) is a global consumer health powerhouse, spun out from Johnson & Johnson in 2022. The company operates through three distinct segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care division is a market leader in over-the-counter (OTC) medications, offering trusted brands like Tylenol, Motrin, and Zyrtec, which dominate the cough, cold, allergy, and pain relief categories. This segment also includes nicotine cessation products under Nicorette and digestive health solutions like Imodium, catering to everyday health needs.

The Skin Health and Beauty segment boasts a robust portfolio of personal care brands, including Neutrogena, Aveeno, and Dr. Ci:Labo. These brands are recognized for their dermatologically tested products, ranging from face and body care to sun and hair products. This division capitalizes on the growing demand for science-backed, premium skincare and beauty products, positioning Kenvue as a key player in the $500 billion global beauty and personal care market.

The Essential Health segment focuses on daily wellness and hygiene products, featuring iconic brands like Listerine, Johnsons, and Band-Aid. This division also includes baby care, womens health, and wound care products, such as Johnsons baby lotions and ointments, as well as feminine hygiene products under Stayfree and Carefree. These offerings are staples in millions of households, providing steady cash flows and brand loyalty.

From a financial perspective, Kenvue trades on the NYSE under the ticker KVUE, with a market capitalization of ~$38 billion. The stock currently carries a trailing P/E of 36.67 and a forward P/E of 16.37, reflecting expectations of future earnings growth. Its price-to-book ratio of 3.57 and price-to-sales ratio of 2.46 indicate a premium valuation, consistent with its strong brand portfolio and market position. Headquartered in Skillman, New Jersey, Kenvue is well-positioned to leverage its heritage as a J&J spin-off, combining a legacy of innovation with the agility of a standalone company. For more information, visit their website at https://www.kenvue.com.